Publications by authors named "N I Veryugina"
[Capabilities of combined therapy of Alzheimer's disease].
Zh Nevrol Psikhiatr Im S S Korsakova
November 2022
Alzheimer's disease is one of the most common neurodegenerative diseases worldwide and carries a huge social burden. Unfortunately, no disease-modifying drug has been approved so far. Currently approved medications are symptomatic and include two classes: cholinesterase inhibitors, such as donepezil, and NMDA receptor antagonist memantine.
View Article and Find Full Text PDFArticle Synopsis
- New studies show that understanding how people think and feel is super important for helping with mental health diagnoses and treatments.
- Researchers from 12 countries looked at how a person's nationality affects their social thinking skills, finding that where someone is from can really matter.
- The results suggest we need to change how we study and help people with social thinking abilities to make sure it works for everyone, no matter where they live.
Erectile dysfunction (ED) significantly deteriorates the quality of life of patients with Parkinson's disease (PD). Until recently, treatment of ED received insufficient attention. Management of ED in patients with PD requires an integrated and multidisciplinary approach.
View Article and Find Full Text PDF[Event-related potentials in Parkinson's disease].
Zh Nevrol Psikhiatr Im S S Korsakova
January 2015
Cognitive deterioration is not an initial symptom of Parkinson's disease but occurs over the course of the disease with the incidence of dementia. The P300 component of event-related potentials appears to be sensitive to cognitive impairment, and has been used to examine cognitive functions in Parkinson's disease. Although many studies have shown that P300 latency and amplitude are correlated with cognitive functions, there is a sufficient amount of controversial results.
View Article and Find Full Text PDF